Cardiopulmonary Resuscitation (CPR) Devices Market Size, Share and Growth Outlook, 2026

Cardiopulmonary Resuscitation (CPR) Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Cardiopulmonary Resuscitation (CPR) Devices Market size is forecast to increase from $169.83 Million in 2026 to $372.06 Million in 2034 at a CAGR of 10.3% between 2026 and 2034.

The Cardiopulmonary Resuscitation (CPR) Devices market report provides detailed analysis and outlook of Cardiopulmonary Resuscitation (CPR) Devices segments including By Product Category (Cardiopulmonary Exercise Testing, Stress ECG Systems, Stress Blood Pressure Monitors, Pulse Oximeters, Imaging Modalities ), By Device Modality (Stationary, Portable, Wearable and Patch-Based Systems), By Physiological Parameter Monitored (Oxygen Uptake, Carbon Dioxide Output, Minute Ventilation, Anaerobic Threshold ), By End-User (Diagnostic Laboratories and Imaging Centers, Hospitals and Multi-Specialty Clinics, Specialty Cardiology and Pulmonology Practices, Ambulatory Care Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Cardiopulmonary Resuscitation (CPR) Devices Industry Overview

Advancements in Resuscitation Technology Supporting Emergency Cardiac Care

The cardiopulmonary resuscitation (CPR) devices industry continues to evolve through innovations in automated compression systems, defibrillation technologies, real-time feedback platforms, and evidence-based resuscitation protocols. Rising emphasis on improving survival outcomes from sudden cardiac arrest has encouraged healthcare providers, emergency medical services, and public health organizations to adopt advanced CPR technologies that enhance the quality and consistency of resuscitation efforts. The industry is increasingly focused on mechanical automation, user-guided intervention systems, and standardized deployment frameworks designed to optimize emergency cardiovascular care across both clinical and community settings.

Device Reliability and Safety Remaining Industry Priorities

Product safety and operational reliability remain critical considerations within the CPR devices market. ZOLL Circulation, Inc. initiated a voluntary high-priority recall involving its AutoPulse Nxt Resuscitation System after the FDA identified a mechanical failure code capable of causing inadequate compression depth or interruption of automated chest compressions. In response, the company launched a comprehensive corrective action program that includes component replacement, deployment of temporary loaner devices, and installation of a modified center pulley assembly to improve alignment within the automated mechanical CPR platform. This development highlights the industry's continued focus on maintaining device performance standards and ensuring reliable operation during life-saving resuscitation procedures.

Public Access Defibrillation Programs Expanding Community Preparedness

Manufacturers are increasingly supporting public health initiatives designed to improve bystander response during sudden cardiac arrest events. ZOLL Medical Corporation expanded its “Anything Can Happen. Anyone Can Help.”™ deployment program through broader equipment donations and training initiatives targeting youth athletic organizations. The initiative distributes automated external defibrillators equipped with Real CPR Help® technology, which provides real-time visual and voice-guided feedback to assist rescuers in maintaining appropriate compression depth and rate. Such programs reflect the growing importance of public access defibrillation and user-friendly CPR technologies in strengthening community emergency response capabilities.

Clinical Guidelines Driving Standardized Mechanical CPR Adoption

Updated clinical recommendations are shaping the deployment of automated chest compression technologies across healthcare systems. The International Liaison Committee on Resuscitation and the American Heart Association Advanced Life Support Task Force published updated Consensus on Science with Treatment Recommendations (CoSTR) guidance outlining specific indications for mechanical CPR device utilization. The framework standardizes the use of automated compression systems during prolonged ambulance transport and specialized coronary angioplasty procedures where manual compressions may be impractical or unsafe. These guideline updates are supporting broader adoption of mechanical CPR devices while reinforcing evidence-based practices for advanced resuscitation care.

Cardiopulmonary Resuscitation (CPR) Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Cardiopulmonary Resuscitation (CPR) Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- ZOLL Medical Corporation (Asahi Kasei), Stryker Corporation (Physio-Control), Medtronic plc, Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Schiller AG, Nihon Kohden Corporation, Mindray Medical International Limited, Michigan Instruments, Inc., Defibtech, LLC. The Cardiopulmonary Resuscitation (CPR) Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Cardiopulmonary Resuscitation (CPR) Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Cardiopulmonary Resuscitation (CPR) Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Cardiopulmonary Resuscitation (CPR) Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Cardiopulmonary Resuscitation (CPR) Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Cardiopulmonary Resuscitation (CPR) Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Cardiopulmonary Resuscitation (CPR) Devices industry include- ZOLL Medical Corporation (Asahi Kasei), Stryker Corporation (Physio-Control), Medtronic plc, Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Schiller AG, Nihon Kohden Corporation, Mindray Medical International Limited, Michigan Instruments, Inc., Defibtech, LLC. The Cardiopulmonary Resuscitation (CPR) Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Cardiopulmonary Resuscitation (CPR) Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Cardiopulmonary Resuscitation (CPR) Devices market remains one of the strongest-performing segments in the country.
The US Cardiopulmonary Resuscitation (CPR) Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Cardiopulmonary Resuscitation (CPR) Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Cardiopulmonary Resuscitation (CPR) Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Cardiopulmonary Resuscitation (CPR) Devices markets

Canada's strong Cardiopulmonary Resuscitation (CPR) Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Cardiopulmonary Resuscitation (CPR) Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Cardiopulmonary Resuscitation (CPR) Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Cardiopulmonary Resuscitation (CPR) Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Cardiopulmonary Resuscitation (CPR) Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Cardiopulmonary Resuscitation (CPR) Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Cardiopulmonary Resuscitation (CPR) Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Cardiopulmonary Resuscitation (CPR) Devices sales through 2034

France Cardiopulmonary Resuscitation (CPR) Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Cardiopulmonary Resuscitation (CPR) Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Cardiopulmonary Resuscitation (CPR) Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Cardiopulmonary Resuscitation (CPR) Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Cardiopulmonary Resuscitation (CPR) Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Cardiopulmonary Resuscitation (CPR) Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Cardiopulmonary Resuscitation (CPR) Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Cardiopulmonary Resuscitation (CPR) Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Cardiopulmonary Resuscitation (CPR) Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Cardiopulmonary Resuscitation (CPR) Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Cardiopulmonary Resuscitation (CPR) Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Cardiopulmonary Resuscitation (CPR) Devices Market Segmentation

By Product Category
Cardiopulmonary Exercise Testing
Stress ECG Systems
Stress Blood Pressure Monitors
Pulse Oximeters
Imaging Modalities
By Device Modality
Stationary
Portable
Wearable and Patch-Based Systems
By Physiological Parameter Monitored
Oxygen Uptake
Carbon Dioxide Output
Minute Ventilation
Anaerobic Threshold
By End-User
Diagnostic Laboratories and Imaging Centers
Hospitals and Multi-Specialty Clinics
Specialty Cardiology and Pulmonology Practices
Ambulatory Care Centers

Top Companies in Cardiopulmonary Resuscitation (CPR) Devices Industry

ZOLL Medical Corporation (Asahi Kasei)
Stryker Corporation (Physio-Control)
Medtronic plc
Koninklijke Philips N.V.
Drägerwerk AG & Co. KGaA
Schiller AG
Nihon Kohden Corporation
Mindray Medical International Limited
Michigan Instruments, Inc.
Defibtech, LLC

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025